Dr Slade Jensen is a group leader of the Antibiotic Resistance and Mobile Elements Group (ARMEG), which was founded by the Microbiology and Infectious Diseases Unit, School of Medicine, University of Western Sydney, and is based at the Ingham Institute for Applied Medical Research.
Strains of methicillin-resistant Staphylococcus aureus (MRSA) are a major cause of hospital-acquired infections around the world and are an emerging cause of infections in the wider community. In an attempt to address this global healthcare issue the laboratory's research program focuses predominantly on various aspects of this important human pathogen.
The groups' current research areas include:
-MRSA ST239 genome evolution (Liverpool Hospital)
-Staphylococcal multiresistance plasmids
-Community MRSA in southwest Sydney
-Mechanisms of antibiotic resistance in clinically-important bacteria
-Infection prevention and control of multiresistant bacteria